Have a personal or library account? Click to login
Usability application of multiplex polymerase chain reaction in the diagnosis of microorganisms isolated from urine of patients treated in cancer hospital Cover

Usability application of multiplex polymerase chain reaction in the diagnosis of microorganisms isolated from urine of patients treated in cancer hospital

Open Access
|Jul 2013

References

  1. 1. Cybulski Z, Kjaeldgaard P. Resistance to oral antibiotics in urinary coliform strains isolated between 2000 and 2008 in Sønderborg area, Denmark. Int JAntimicrob Agents 2010; 35: 516-7.10.1016/j.ijantimicag.2010.01.009
  2. 2. Bouza E, San Juan R, Muñoz P, Voss A, Kluytmans J. Co-operative Group of the European Study Group on Nosocomial Infections: A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect 2001; 7: 523-31.10.1046/j.1198-743x.2001.00326.x
  3. 3. Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ. Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill. J Crit Care 2002; 17: 50-7.10.1053/jcrc.2002.33029
  4. 4. Warren JW. Catheter-associated urinary tract infections. Int J Antimicrob 2001; 17: 299-303.10.1016/S0924-8579(00)00359-9
  5. 5. Conde S, Borrego M, TeixeiraT, Teixeira R, Corbal M, Sá A, et al. Impact of neoadjuvant chemoradiation on pathologic response and survival of patients with locally advanced rectal cancer. Rep Pract Oncol Radiother 2010; 15: 51-9.10.1016/j.rpor.2010.04.002386320824376924
  6. 6. Geerlings SE, van den Broek PJ, van Haarst EP, Vleming LJ, van Haaren KM, Janknegt R, et al. Optimisation of the antibiotic policy in the Netherlands. X. The SWAB guideline for antimicrobial treatment of complicated urinary tract infections. Ned Tijdschr Geneeskd 2006; 150: 2370-6.
  7. 7. Karupati P, Chow C, Kumarasinghe G, Poh CL. Rapid detection of Klebsiellapneumoniae from blood culture bottles by real time PCR. J Clin Microbiol 2004; 42: 1337-40.10.1128/JCM.42.3.1337-1340.200435684015004113
  8. 8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI Document M100- S17. Vol. 27 No 1. Wayne PA; 2007.10.1201/9781420014495.ch1
  9. 9. Church D, Gregson D. Screening urine samples for significant bacteriuria in the clinical microbiology laboratory. Clin Microbiol Newsletter 2004; 26: 179-83.10.1016/j.clinmicnews.2004.11.003
  10. 10. Bartges JW. Diagnosis of urinary tract infections. Vet Clin North Am SmallAnim Pract 2004; 34: 923-33.10.1016/j.cvsm.2004.03.00115223209
  11. 11. Lehmann LE, Hauser S, Malinka T, Klaschik S, Weber SU, Schewe JC, et al. Rapid qualitative urinary tract infection pathogen identification by SeptiFast Real-time PCR. PLoS One 2011; 6(2): e17146.10.1371/journal.pone.0017146304022921359187
  12. 12. Ke D, Picard FJ, Martineau F, Ménard C, Roy PH, Ouellette M, et al. Development of a PCR assay for rapid detection of enterococci. J ClinMicrobiol 1999; 37: 3497-503.10.1128/JCM.37.11.3497-3503.19998567710523541
  13. 13. Lehmann LE, Hauser S, Malinka T, Klaschik S, Stüber F, Book M. Real-time polymerase chain- reaction detection of pathogens is feasible to suplement the diagnostic sequence for urinary tract infections. BJU Int 2010; 106: 114-20.10.1111/j.1464-410X.2009.09017.x19874298
  14. 14. Elnifro EM, Ashi AM, Cooper RJ, Klapper PE. Multiplex PCR: optimization and application in diagnostic virology. Clin Microb Rev 2000; 13: 559-70.10.1128/CMR.13.4.5598894911023957
  15. 15. Chun JY, Kim KJ, Hwang IT, Kim YJ, Lee DH, Lee IK, et al. Dual priming oligonucleotide system for the multiplet detection of respiratory viruses and SNP genotyping of CYP2C19 gene. Nucleic Acids Res. 2007; 35(6): e40.10.1093/nar/gkm051187460617287288
  16. 16. Horii T, Ohtsuka H, Osaki M, Ohkuni H. Use of a dual priming oligonucleotide system to detect multiple sexually transmitted pathogens in clinical specimens. Lett Appl Microbiol 2009; 49: 46-52.10.1111/j.1472-765X.2009.02618.x19413770
  17. 17. Siddiqui H, Lagesen K, Nederbragt AJ, Jeansson SL, Jakobsen KS. Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiol 2012; 12: 205.10.1186/1471-2180-12-205353870222974186
  18. 18. Siddiqui H, Nederbragt AJ, Lagesen K, Jeansson SL, Jakobsen KS. Assessing diversityof the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol 2011; 11: 244.10.1186/1471-2180-11-244322871422047020
  19. 19. Nelson DE, Van Der Pol B, Dong Q, Revanna KV, Fan B, Easwaran S, et al. Characteristic male urine microbiomes associated with asymptomatic sexually transmitted infection. PLoS One 2010; 5(11): e14116.10.1371/journal.pone.0014116299135221124791
  20. 20. Dong Q, Nelson DE, Toh E, Diao L, Gao X, Fortenberry JD, et al. The microbial communities in male first catch urine are highly similar to those in paired urethral swab specimens. PLoS One 2011; 6(5): e19709.10.1371/journal.pone.0019709309438921603636
  21. 21. Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M, et al. Evidence of uncultivated bacteria in theadult female bladder. J Clin Microbiol 2012; 50: 1376-83.10.1128/JCM.05852-11331854822278835
  22. 22. Tan CK, Ulett KB, Steele M, Benjamin WH Jr, Ulett GC. Prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: a 4-year retrospective study in adult patients. BMC Infect Dis 2012; 12: 273.10.1186/1471-2334-12-273
  23. 23. Thue G, Baerheim A, Bjelkaroy WI, Digranes A. Urindyppekultur i allmennpraksis. Tidsskr Nor Legeforen 2010; 130: 483-6.10.4045/tidsskr.09.0658
  24. 24. Algara M, Arenas M, De las Peñas D, Bayo E, Muñoz J, Carceller JA, et al. Radiation techniques used in patients with breast cancer: Results of a survey in Spain. Rep Pract Oncol Radiother 2012; 17: 122-8.10.1016/j.rpor.2012.03.007
  25. 25. Lekic M, Kovac V, Triller N, Knez L, Sadikov A, Cufer T. Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting. Radiol Oncol 2012; 46: 54-9.10.2478/v10019-012-0007-1
  26. 26. Ovcaricek T, Frkovic SG, Matos E, Mozina B, Borstnar S. Triple negative breast cancer - prognostic factors and survival. Radiol Oncol 2011; 45: 46-52.10.2478/v10019-010-0054-4
  27. 27. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000: The global picture. Eur J Cancer 2001; 37(Suppl 8): 4-66.10.1016/S0959-8049(01)00267-2
  28. 28. Ulukaya E, Karaagac E, Ari F, Oral AY, Adim SB, Tokullugil AH, et al. Chemotherapy increases caspase-cleaved cytokeratin 18 in the serum of breast cancer patients. Radiol Oncol 2011; 45: 116-22.10.2478/v10019-011-0006-7342372422933944
  29. 29. Khader J, Farah N, Salem A. Bladder preservation by concurrent chemoradiation for muscle-invasive bladder cancer: Applicability in low-income countries. Rep Pract Oncol Radiother 2011; 16: 23-6.10.1016/j.rpor.2011.04.003386313724376977
  30. 30. Gupta R, Schuster M. Quorum sensing modulates colony morphology through alkyl quinolones in Pseudomonas aeruginosa. BMC Microbiology 2012; 12: 3010.1186/1471-2180-12-30336486922404951
  31. 31. Kerr KG, Snelling AM. Pseudomonas aeruginosa: a formidable and everpresent adversary. J Hosp Infect 2009; 73: 338-44.10.1016/j.jhin.2009.04.02019699552
  32. 32. Cybulski Z, Roszak A, Talaga Z, Grabiec A, Kaźmierska J. Urinary tract infections in patients with malignant neoplasms of the genitourinary system. RepPract Oncol Radiother 2005, 10: 23-6.10.1016/S1507-1367(05)71078-6
  33. 33. Christiaens T, De Backer D, Burgers J, Baerheim A. Guidelines, evidence, and cultural factors. Scand J Prim Health Care 2004; 22: 141-5.10.1080/0281343041000652115370789
  34. 34. Nicolle LE. A practical guide to antimicrobial management of complicated urinary tract infection. Drug Aging 2001; 18: 243-54.10.2165/00002512-200118040-0000211341472
  35. 35. Pallett A, Hand K. Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria. J AntimicrobChemother 2010; 65(Suppl 3): 25-33.10.1093/jac/dkq29820876625
  36. 36. Karlowsky JA, Lagace´-Wiens PRS, Simner PJ, DeCorby MR, Adam HJ, Walkty A, et al. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD Surveillance Study. Antimicrob Agents Chemother 2011; 55: 3169-75.10.1128/AAC.00066-11312242921537027
  37. 37. van der Starre WE, van Nieuwkoop C, Paltansing S, van’t Wout JW, Groeneveld GH, Becker MJ, et al. Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. ClinInfect Dis 2010; 50(11): e69-72.10.1086/65265720420504
DOI: https://doi.org/10.2478/raon-2013-0044 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 296 - 303
Published on: Jul 30, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2013 Zefiryn Cybulski, Katarzyna Schmidt, Alicja Grabiec, Zofia Talaga, Piotr Bociąg, Jacek Wojciechowicz, Andrzej Roszak, Witold Kycler, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.